Literature DB >> 22572832

Study on the association of Helicobacter species with viral hepatitis-induced hepatocellular carcinoma.

Alexander Krüttgen1, Hans-Peter Horz, Josefine Weber-Heynemann, Mihael Vucur, Christian Trautwein, Gerhard Haase, Tom Luedde, Christoph Roderburg.   

Abstract

Helicobacter species are important pathogens and previous studies in mice suggested a link between colonization by Helicobacter hepaticus (H. hepaticus) and hepatocellular carcinoma (HCC). This study aimed at corroborating this potential link in human patients. We used a sensitive and specific Helicobacter ssp PCR assay to screen stool samples from a collective of patients with viral-induced HCC (hepatitis B or hepatitis C) and a control group for presence of Helicobacter ssp DNA. Although retrieving DNA of H. pylori and H. canadensis from stool samples of non-HCC patients, we found no evidence indicating the presence of H. hepaticus in HCC-patients with chronic hepatitis B or hepatitis C. Interestingly we found H. canadensis in a stool sample of a patient presenting with diarrhea. Taken together, our data argue against a pathogenic role of H. hepaticus in viral-induced HCC. Yet, our results do not exclude a role of H. hepaticus in those HCC cases caused by other carcinogens, such as aflatoxin. Moreover, we speculate that H. canadensis might be a novel gastrointestinal pathogen.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22572832      PMCID: PMC3427215          DOI: 10.4161/gmic.19922

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  23 in total

1.  Distance burning: how gut microbes promote extraintestinal cancers.

Authors:  Arlin B Rogers
Journal:  Gut Microbes       Date:  2011 Jan-Feb

2.  Improved amplification of microbial DNA from blood cultures by removal of the PCR inhibitor sodium polyanetholesulfonate.

Authors:  D N Fredricks; D A Relman
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

Review 3.  NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma.

Authors:  Tom Luedde; Robert F Schwabe
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02       Impact factor: 46.802

4.  Identification of helicobacter species in human liver samples from patients with primary hepatocellular carcinoma.

Authors:  Y Huang; X-G Fan; Z-M Wang; J-H Zhou; X-F Tian; N Li
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

5.  Triplex PCR for the simultaneous detection of Pseudomonas aeruginosa, Helicobacter hepaticus, and Salmonella typhimurium.

Authors:  Eui-Suk Jeong; Kyoung-Sun Lee; Seung-Ho Heo; Jin-Hee Seo; Yang-Kyu Choi
Journal:  Exp Anim       Date:  2011

6.  Detection of Helicobacter pylori DNA by a simple stool PCR method in adult dyspeptic patients.

Authors:  Nazime Sen; Ozlem Yilmaz; Ilkay Simşek; Ahmet Ali Küpelioğlu; Hülya Ellidokuz
Journal:  Helicobacter       Date:  2005-08       Impact factor: 5.753

7.  Stool polymerase chain reaction for Helicobacter pylori detection and clarithromycin susceptibility testing in children.

Authors:  Andreas Vécsei; Albina Innerhofer; Christa Binder; Heidi Gizci; Karin Hammer; Andrea Bruckdorfer; Stefan Riedl; Helmut Gadner; Alexander M Hirschl; Athanasios Makristathis
Journal:  Clin Gastroenterol Hepatol       Date:  2009-12-28       Impact factor: 11.382

Review 8.  Helicobacter species and liver diseases: association or causation?

Authors:  Rinaldo Pellicano; Armelle Ménard; Mario Rizzetto; Francis Mégraud
Journal:  Lancet Infect Dis       Date:  2008-04       Impact factor: 25.071

9.  Association between entero-hepatic Helicobacter species and Crohn's disease: a prospective cross-sectional study.

Authors:  D Laharie; C Asencio; J Asselineau; P Bulois; A Bourreille; J Moreau; P Bonjean; D Lamarque; A Pariente; J-C Soulé; A Charachon; B Coffin; P Perez; F Mégraud; F Zerbib
Journal:  Aliment Pharmacol Ther       Date:  2009-05-05       Impact factor: 8.171

10.  Genome sequence of the emerging pathogen Helicobacter canadensis.

Authors:  N J Loman; L A S Snyder; J D Linton; R Langdon; A J Lawson; G M Weinstock; B W Wren; M J Pallen
Journal:  J Bacteriol       Date:  2009-06-19       Impact factor: 3.490

View more
  13 in total

Review 1.  Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: Current concepts and perspectives.

Authors:  Juan P Arab; Marco Arrese; Vijay H Shah
Journal:  Hepatol Res       Date:  2020-01-13       Impact factor: 4.288

Review 2.  Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome.

Authors:  Ziying Zhang; Haosheng Tang; Peng Chen; Hui Xie; Yongguang Tao
Journal:  Signal Transduct Target Ther       Date:  2019-10-12

Review 3.  Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy.

Authors:  Murphy L Y Wan; Hani El-Nezami
Journal:  Hepatobiliary Surg Nutr       Date:  2018-02       Impact factor: 7.293

Review 4.  Helicobacter pylori infection and diabetes: is it a myth or fact?

Authors:  Cong He; Zhen Yang; Nong-Hua Lu
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

5.  Publisher Correction: The gut-liver axis and the intersection with the microbiome.

Authors:  Anupriya Tripathi; Justine Debelius; David A Brenner; Michael Karin; Rohit Loomba; Bernd Schnabl; Rob Knight
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-12       Impact factor: 46.802

Review 6.  From the stomach to other organs: Helicobacter pylori and the liver.

Authors:  Marek Waluga; Michał Kukla; Michał Żorniak; Agata Bacik; Rafał Kotulski
Journal:  World J Hepatol       Date:  2015-08-28

7.  Helicobacter pylori infection does not promote hepatocellular cancer in a transgenic mouse model of hepatitis C virus pathogenesis.

Authors:  Alexis García; Yan Feng; Nicola M A Parry; Amanda McCabe; Melissa W Mobley; Kvin Lertpiriyapong; Mark T Whary; James G Fox
Journal:  Gut Microbes       Date:  2013-08-07

Review 8.  The gut-liver axis and the intersection with the microbiome.

Authors:  Anupriya Tripathi; Justine Debelius; David A Brenner; Michael Karin; Rohit Loomba; Bernd Schnabl; Rob Knight
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-07       Impact factor: 46.802

Review 9.  The microbiome, genetics, and gastrointestinal neoplasms: the evolving field of molecular pathological epidemiology to analyze the tumor-immune-microbiome interaction.

Authors:  Kosuke Mima; Keisuke Kosumi; Yoshifumi Baba; Tsuyoshi Hamada; Hideo Baba; Shuji Ogino
Journal:  Hum Genet       Date:  2020-11-12       Impact factor: 4.132

Review 10.  Targeting Microbiota: What Do We Know about It at Present?

Authors:  Aleksejs Derovs; Sniedze Laivacuma; Angelika Krumina
Journal:  Medicina (Kaunas)       Date:  2019-08-10       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.